GRO Biosciences
About:
GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.
Website: https://www.grobio.com
Twitter/X: gro_bio
Top Investors: Alumni Ventures, National Science Foundation, Digitalis Ventures, Redmile Group, Atlas Venture
Description:
GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. The company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency, stability, and targeted delivery. GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders, and autoimmunity.
$92.6M
Less than $1M
Boston, Massachusetts, United States
2016-01-01
Andrew Ellington, Benjamin Stranges, Christopher Gregg, Daniel J. Mandell, Marc Lajoie, Ross Thyer
11-50
2024-07-19
Private
© 2025 bioDAO.ai